106 related articles for article (PubMed ID: 30763811)
1. Functional Expression of Mucin1 in Human Duodenal Adenocarcinoma.
Shiba S; Miki A; Ohzawa H; Teratani T; Sakuma Y; Lefor AK; Kitayama J; Sata N
J Surg Res; 2019 Jun; 238():79-89. PubMed ID: 30763811
[TBL] [Abstract][Full Text] [Related]
2. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
[No Abstract] [Full Text] [Related]
3. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
[TBL] [Abstract][Full Text] [Related]
4. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model.
Wu G; Maharjan S; Kim D; Kim JN; Park BK; Koh H; Moon K; Lee Y; Kwon HJ
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987260
[TBL] [Abstract][Full Text] [Related]
5. Impact of Mucin1 knockdown on the phenotypic characteristics of the human hepatocellular carcinoma cell line SMMC-7721.
Li Q; Wang F; Liu G; Yuan H; Chen T; Wang J; Xie F; Zhai R; Wang F; Guo Y; Ni W; Tai G
Oncol Rep; 2014 Jun; 31(6):2811-9. PubMed ID: 24737121
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway.
Zhao P; Meng M; Xu B; Dong A; Ni G; Lu L
Cancer Biomark; 2017 Dec; 20(4):469-476. PubMed ID: 28869438
[TBL] [Abstract][Full Text] [Related]
7. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
Liang X; Li Z; Men Q; Li Y; Li H; Chong T
Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
[TBL] [Abstract][Full Text] [Related]
8. MUC1 Knockdown With RNA Interference Inhibits Pancreatic Cancer Growth.
Yuan Z; Liu X; Wong S; Machan JT; Chung MA
J Surg Res; 2009 Nov; 157(1):e39-46. PubMed ID: 19482310
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.
Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D
Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of MUC1 by its novel activator 14-3-3ζ promotes tumor invasion and indicates poor prognosis in lung adenocarcinoma.
Xue M; Tao W
Oncol Rep; 2017 Nov; 38(5):2637-2646. PubMed ID: 28901525
[TBL] [Abstract][Full Text] [Related]
11. Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma.
Lappi-Blanco E; Mäkinen JM; Lehtonen S; Karvonen H; Sormunen R; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Kaarteenaho R
Tumour Biol; 2016 Oct; 37(10):13811-13820. PubMed ID: 27481516
[TBL] [Abstract][Full Text] [Related]
12. Protective and predictive role of Mucin1 in sepsis-induced ALI/ARDS.
Wang YM; Qi X; Gong FC; Chen Y; Yang ZT; Mao EQ; Chen EZ
Int Immunopharmacol; 2020 Jun; 83():106438. PubMed ID: 32247267
[TBL] [Abstract][Full Text] [Related]
13. Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.
Nath S; Roy LD; Grover P; Rao S; Mukherjee P
Pancreas; 2015 Aug; 44(6):909-17. PubMed ID: 26035123
[TBL] [Abstract][Full Text] [Related]
14. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer.
Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D
Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010
[TBL] [Abstract][Full Text] [Related]
15. Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration.
Cascio S; Farkas AM; Hughey RP; Finn OJ
Oncotarget; 2013 Oct; 4(10):1686-97. PubMed ID: 24072600
[TBL] [Abstract][Full Text] [Related]
16. Expression of human full-length MUC1 inhibits the proliferation and migration of a B16 mouse melanoma cell line.
Wang F; Li Q; Ni W; Fang F; Sun X; Xie F; Wang J; Wang F; Gao S; Tai G
Oncol Rep; 2013 Jul; 30(1):260-8. PubMed ID: 23633115
[TBL] [Abstract][Full Text] [Related]
17. O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.
Premaratne P; Welén K; Damber JE; Hansson GC; Bäckström M
Tumour Biol; 2011 Feb; 32(1):203-13. PubMed ID: 20872286
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate.
Adil Butt M; Pye H; Haidry RJ; Oukrif D; Khan SU; Puccio I; Gandy M; Reinert HW; Bloom E; Rashid M; Yahioglu G; Deonarain MP; Hamoudi R; Rodriguez-Justo M; Novelli MR; Lovat LB
Oncotarget; 2017 Apr; 8(15):25080-25096. PubMed ID: 28212575
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival.
Hiraki T; Yamada S; Higashi M; Hatanaka K; Yokoyama S; Kitazono I; Goto Y; Kirishima M; Batra SK; Yonezawa S; Tanimoto A
Histol Histopathol; 2017 Jun; 32(6):585-596. PubMed ID: 27672051
[TBL] [Abstract][Full Text] [Related]
20. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
